Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Coca-Cola on erlotinib absorption with or without proton pump inhibitor use
NL-OMON40431Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of erlotinib in bronchial carcinoma (2 arms), sponsored by Erasmus MC. Primary endpoint: Differences in erlotinib bioavailability during coca-cola intake vs. water intake (+/- PPI). Started Apr 2014; status: active, not recruiting.
02
Drugs
erlotinib
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on NL-OMON40431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40431.